As of Aug 30
| -0.02 / -0.80%|
The 3 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +203.64% increase from the last price of 2.47.
The current consensus among 3 polled investment analysts is to Buy stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.